Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis

2025/10/20 by Siddharth Singh, M. Hassan Murad, M.Hassan Murad +9 · 5 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Autoimmune and Inflammatory Disorders #Rheumatoid Arthritis Research and Therapies

paper · pdf · doi:10.1053/j.gastro.2025.08.032

Citations

• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
• AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
• AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
• Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis
• Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States
• Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis

Cited by

• Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy. [europepmc]
• Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions. [europepmc]
• Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients With Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis With Meta-Regression. [europepmc]
• From Conventional Therapy to Precision Medicine in Inflammatory Bowel Disease: A State-of-the-Art Review. [europepmc]
• ANGPT1-GABARAP axis modulates NLRP3 inflammasome-mediated pyroptosis in Crohn's disease. [europepmc]